30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kurt Gustafson

Track

Insider profile

Currently holds positions in Spectrum Pharmaceuticals Inc, Xencor Inc and Niagen Bioscience Inc

Performance

Overall performance
3.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 91% 68% 82%
Transactions
15 13% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 94%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Spectrum Pharmaceuticals Inc June 1, 2013 -
Independent Director Xencor Inc July 14, 2014 -
Lead Independent Director Niagen Bioscience Inc June 22, 2018 -
Independent Director Niagen Bioscience Inc Jan. 1, 2017 - June 22, 2018
Director Niagen Bioscience Inc Oct. 21, 2016 - Jan. 1, 2017
Chief Financial Officer, Vice President Halozyme Therapeutics Inc Jan. 1, 2011 - May 20, 2013
Kurt Gustafson's trades of Xencor Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-15
US Xencor Inc (XNCR)
PrS Proposed sale
90,591
453.11
US$3,024,575 		90,591 453.11 US$3,024,575
2026-04-07 2026-04-07
US OmniAb Inc (OABI)
PrS Proposed sale
31,984
57.83
US$705,349 		31,984 57.83 US$705,349
2026-04-07 2026-04-07
US OmniAb Inc (OABI)
S Sale
2,209 +46.7%
476.69
US$1,564,385 		2,209 +46.7% 476.69 US$1,564,385
2026-02-18 2026-02-18
US OmniAb Inc (OABI)
S Sale
9,301 -3.3%
1.71
US$15,905 		9,301 -3.3% 1.71 US$15,905
2026-02-17 2026-02-18
US OmniAb Inc (OABI)
PrS Proposed sale
9,173
1.70
US$15,594 		9,173 1.70 US$15,594
2026-02-17 2026-02-17
US OmniAb Inc (OABI)
S Sale
6,828 -2.6%
1.70
US$11,608 		6,828 -2.6% 1.70 US$11,608
2026-02-17 2026-02-17
US OmniAb Inc (OABI)
PrS Proposed sale
6,891
1.70
US$11,715 		6,891 1.70 US$11,715
2025-12-09 2025-12-08
US OmniAb Inc (OABI)
S Sale
23,922 -8.6%
1.96
US$46,887 		23,922 -8.6% 1.96 US$46,887
2025-12-08 2025-12-08
US OmniAb Inc (OABI)
PrS Proposed sale
23,922
1.96
US$46,910 		23,922 1.96 US$46,910
2025-06-16 2025-06-16
US Xencor Inc (XNCR)
PrS Proposed sale
2,993
9.19
US$27,506 		2,993 9.19 US$27,506
2025-06-16 2025-06-16
US Xencor Inc (XNCR)
PlS Planned sale
2,993 -12.9%
9.22
US$27,595 		2,993 -12.9% 9.22 US$27,595
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
PrS Proposed sale
7,206
2.00
US$14,396 		7,206 2.00 US$14,396
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
S Sale
7,206 -3.1%
2.00
US$14,412 		7,206 -3.1% 2.00 US$14,412
2025-04-01 2025-04-01
US OmniAb Inc (OABI)
PrS Proposed sale
11,963
2.37
US$28,351 		11,963 2.37 US$28,351
2025-04-01 2025-04-01
US OmniAb Inc (OABI)
S Sale
11,963 -5.2%
2.37
US$28,352 		11,963 -5.2% 2.37 US$28,352
2025-02-19 2025-02-19
US OmniAb Inc (OABI)
S Sale
7,255 -3.4%
3.67
US$26,626 		7,255 -3.4% 3.67 US$26,626
2025-02-18 2025-02-19
US OmniAb Inc (OABI)
PrS Proposed sale
5,188
3.68
US$19,092 		5,188 3.68 US$19,092
2025-01-22 2025-01-21
US OmniAb Inc (OABI)
S Sale
15,526 -6.8%
3.24
US$50,304 		15,526 -6.8% 3.24 US$50,304
2025-01-21 2025-01-21
US OmniAb Inc (OABI)
PrS Proposed sale
15,526
3.24
US$50,271 		15,526 3.24 US$50,271
2024-12-10 2024-12-09
US OmniAb Inc (OABI)
S Sale
23,871 -10.6%
4.13
US$98,587 		23,871 -10.6% 4.13 US$98,587
2024-12-09 2024-12-09
US OmniAb Inc (OABI)
PrS Proposed sale
23,871
4.13
US$98,476 		23,871 4.13 US$98,476
2024-10-01 2024-09-27
US Xencor Inc (XNCR)
PlS Planned sale
2,503 -20.9%
20.68
US$51,762 		2,503 -20.9% 20.68 US$51,762
2024-09-27 2024-09-27
US Xencor Inc (XNCR)
PrS Proposed sale
2,503
20.68
US$51,762 		2,503 20.68 US$51,762
2024-04-09 2024-04-08
US OmniAb Inc (OABI)
S Sale
6,954 -3.8%
5.27
US$36,648 		6,954 -3.8% 5.27 US$36,648
2024-04-08 2024-04-08
US OmniAb Inc (OABI)
PrS Proposed sale
6,954
5.27
US$36,675 		6,954 5.27 US$36,675
2024-04-02 2024-04-01
US OmniAb Inc (OABI)
S Sale
11,849 -6.5%
5.46
US$64,696 		11,849 -6.5% 5.46 US$64,696
2024-04-01 2024-04-01
US OmniAb Inc (OABI)
PrS Proposed sale
11,849
5.46
US$64,696 		11,849 5.46 US$64,696
2024-03-07 2024-03-06
US Xencor Inc (XNCR)
S Sale
14,000 -70.0%
23.18
US$324,453 		14,000 -70.0% 23.18 US$324,453
2024-03-06 2024-03-06
US Xencor Inc (XNCR)
PrS Proposed sale
14,000
23.18
US$324,453 		14,000 23.18 US$324,453
2022-11-29 2022-11-28
US OmniAb Inc (OABI)
B Purchase
10,000 +6.2%
2.81
US$28,100 		10,000 +6.2% 2.81 US$28,100
2022-03-16 2022-03-16
PlS Planned sale
16,318 -4.9%
0.71
US$11,521 		16,318 -4.9% 0.71 US$11,521
2022-03-16 2022-03-15
PlS Planned sale
20,653 -5.8%
0.71
US$14,560 		20,653 -5.8% 0.71 US$14,560
2022-02-24 2022-02-24
PlS Planned sale
15,958 -4.3%
0.64
US$10,213 		15,958 -4.3% 0.64 US$10,213
2022-02-24 2022-02-23
PlS Planned sale
20,215 -5.2%
0.70
US$14,211 		20,215 -5.2% 0.70 US$14,211
2021-03-17 2021-03-16
PlS Planned sale
16,318 -3.9%
3.69
US$60,213 		16,318 -3.9% 3.69 US$60,213
2021-03-17 2021-03-15
PlS Planned sale
20,365 -4.7%
3.63
US$73,823 		20,365 -4.7% 3.63 US$73,823
2021-02-23 2021-02-22
PlS Planned sale
4,000 -0.9%
3.73
US$14,920 		4,000 -0.9% 3.73 US$14,920
2021-02-23 2021-02-19
PlS Planned sale
4,672 -1.0%
3.64
US$16,992 		4,672 -1.0% 3.64 US$16,992
2021-01-20 2021-01-20
PlS Planned sale
1,944 -0.6%
4.31
US$8,379 		1,944 -0.6% 4.31 US$8,379
2021-01-20 2021-01-19
PlS Planned sale
2,582 -0.8%
3.81
US$9,832 		2,582 -0.8% 3.81 US$9,832
2020-12-16 2020-12-14
PlS Planned sale
25,696 -7.1%
5.00
US$128,480 		25,696 -7.1% 5.00 US$128,480
2020-04-02 2020-04-01
PlS Planned sale
3,135 -0.9%
2.23
US$6,991 		3,135 -0.9% 2.23 US$6,991
2020-04-02 2020-03-31
PlS Planned sale
4,326 -1.2%
2.31
US$9,989 		4,326 -1.2% 2.31 US$9,989
2020-02-21 2020-02-20
PlS Planned sale
3,333 -1.6%
2.85
US$9,499 		3,333 -1.6% 2.85 US$9,499
2020-02-21 2020-02-19
PlS Planned sale
4,733 -2.2%
2.77
US$13,115 		4,733 -2.2% 2.77 US$13,115